Application of miR-21 in diagnosis and treatment of subarachnoid hemorrhage
Patent Information
- Authority / Receiving Office
- CN ยท China
- Current Assignee / Owner
- SHANDONG UNIV QILU HOSPITAL
- Publication Date
- 2020-01-14
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the technical fields of biomedicine and molecular biology, and specifically relates to the application of miR-21 in the diagnosis and treatment of subarachnoid hemorrhage. Background technique
[0002] The information disclosed in the Background of the Invention is only intended to increase the understanding of the general background of the invention, and is not necessarily to be taken as an acknowledgment or any form of suggestion that the information constitutes the prior art that is already known to those skilled in the art.
[0003] Subarachnoid hemorrhage (SAH) is a life-threatening neurological disease with high mortality and disability. With the advancement of neurosurgery diagnosis and treatment technology, many patients can survive, but it is completely difficult to restore normal cognitive function, and suffer from cognitive impairment, which reduces their quality of life. Accumulating evidence shows that early brain...